Development and Expression of Amyloid-β Peptide 42 in Retinal Ganglion Cells in Rats

Anatomical Record

Volumn 294, Issue 8, 2011, Pages 1401-1405

  Wang, Jianqiang ^a   Zhu, Chunfang ^b   Xu, Yirong ^b   Liu, Bin ^b   Wang, Minchen ^b   Wu, Kaiyun ^b  

^a China   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Amyloid peptide 42; Immunocytochemistry; Rat; Retinal ganglion cells; Visual development

Indexed keywords

AMYLOID BETA PROTEIN[1-42];

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; IMMUNOCYTOCHEMISTRY; LIGHT EXPOSURE; MALE; NERVE CELL; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA CELL; RETINA DEVELOPMENT;

AGE FACTORS; AGING; AMYLOID BETA-PEPTIDES; ANIMALS; CRYOULTRAMICROTOMY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; LIGHT; MALE; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; RNA, MESSENGER;

RATTUS;

EID: 79960495664     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21438     Document Type: Article

References (21)

1. Alvarez A, Alarcon R, Opazo C, Campos EO, Munoz FJ, Calderón FH, Dajas F, Gentry MK, Doctor BP, Mello FG, Inestrosa NC. 1988. Stable complex involving acetilcholinesterase and β-amyloid peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J Neurosci 18: 3213-3223.
2. Blanks JC, Hinton DR, Sadun AA, Miller CA. 1989. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res 501: 364-372.
3. Dahlgren KN, Maneli AM, Stine WB, Baker LK, Krafft GA, Mary JL. 2002. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277: 32046-32053.
4. Florent S, Malaplate-Armand C, Youssef I, Kriem B, Koziel V, Escanyé MC, Fifre A, Sponne I, Muller BL, Olivier JL, Pillot T, Oster T. 2006. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-β oligomers. J Neurochem 96: 385-395.
5. Frost D, Gorman PM, Yip CM, Chakrabartty A. 2003. Co-incorporation of A beta 40 and A beta 42 to form mixed pre-fibrillar aggregates. Eur J Biochem 270: 654-663.
6. Games D, Adams R, Alessandrini R, Barbour R, Borthelette P, Blackwell C, Tony Carr, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Zavala MM, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373: 523-527.
7. Goldblum D, Kipfer-Kauer A, Sarra GM, Wolf S, Frueh BE. 2007. Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest Ophthalmol Vis Sci 48: 5085-5090.
8. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch C, Krafft GA, Klein WL. 2003. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100: 10417-10422.
9. Hinton DR, Sadun AA, Blanks JC, Miller CA. 1986. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 315: 485-487.
10. Kim HJ, Chae SC, Lee DK, Chromy B, Lee SC, Park YC, Klein WL, Krafft GA, Hong ST. 2003. Selective neuronal degeneration induced by soluble oligomeric amyloid beta-protein. FASEB J 17: 118-120.
11. Kriem B, Sponne I, Fifre A, Armand CM, Pillot KL, Koziel V, Yen-Potin FT, Bihain B, Oster T, Olivier JL, Pillot T. 2005. Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-β peptide. FASEB J 19: 85-87.
12. McKinnon SJ. 2003. Glaucoma: ocular Alzheimer's disease? Front Biosci 1: 1140-56.
13. Mullan M, Crawford F. 1993. Genetic and molecular advances in Alzheimer disease. Trends Neurosci 16: 398.
14. Pike CJ, Cummings BJ, Cotman CW. 1992. Beta amyloid induced neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuroreport 3: 769-775.
15. Schmitz A, Schneider A, Kummer MP, Herzog V. 2004. Endoplasmic reticulum-localized amyloid β-peptide is degraded in the cytosol by two distinct degradation pathways. Traffic 5: 89-101.
16. Selkoe DJ. 1994. Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci 17: 489-517.
17. Selkoe DJ. 2000. Toward a comprehensive theory for Alzheimer's disease hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann NY Acad Sci 924: 17-25.
18. Selkoe DJ. 2004. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med 140: 627-638.
19. Sponne I, Fifre A, Koziel V, Oster T, Olivier JL, Pillot T. 2004. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide. FASEB J 18: 836-838.
20. Tanzi RE, Moir RD, Wagner SL. 2004. Clearance of Alzheimer's Aβ peptide: the many roads to perdition. Neuron 43: 605-608.
21. Yoshida T, Fukatsu R, Tsuzuki K, Aizawa Y, Hayashi Y, Sasaki N, Takamaru Y, Fujii N, Takahata N. 1997. Amyloid precursor protein, Aβ and amyloid-associated proteins involved in chloroquine retinopathy in rats-immunopathological studies. Brain Res 764: 283-288.